Protagonist’s story gets a happy ending as FDA’s hold swiftly lifted on rusfertide program
Protagonist’s story gets a happy ending as FDA’s hold swiftly [...]
Merck makes beeline to FDA, seeking approval for COVID-19 antiviral 10 days after reporting data
Merck makes beeline to FDA, seeking approval for COVID-19 antiviral [...]
Novel vaccine strategy protects mice from COVID-19 and 4 related coronaviruses
Novel vaccine strategy protects mice from COVID-19 and 4 related [...]
Pfizer, Bayer-backed Pyxis ups IPO price as biotech’s public run continues unabated
Pfizer, Bayer-backed Pyxis ups IPO price as biotech’s public run [...]
Takeda’s transplant drug gets unanimous support of FDA AdComm despite concerns over diversity of its study
Takeda’s transplant drug gets unanimous support of FDA AdComm despite [...]
Mirati, Sanofi join forces in lung cancer with a KRAS-SHP2 combo approach
Mirati, Sanofi join forces in lung cancer with a KRAS-SHP2 [...]
FDA stops all Allogene’s CAR-T trials over safety scare, raising questions about future of gene editing
FDA stops all Allogene’s CAR-T trials over safety scare, raising [...]
Bristol Myers Squibb’s deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster
Bristol Myers Squibb’s deucravacitinib flunks midphase IBD trial, raising questions [...]
Denali makes ALS play, hustling Sanofi-partnered drug into phase 2 and sharing early data on internal program
Denali makes ALS play, hustling Sanofi-partnered drug into phase 2 [...]
Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future of neuroscience R&D
Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future [...]